NCT03423628 2025-12-22
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
AstraZeneca
Phase 1 Recruiting
AstraZeneca
Plus Therapeutics
Biocept, Inc.
Angiochem Inc
Pacira Pharmaceuticals, Inc